Palasis Maria 4
4 · Lyra Therapeutics, Inc. · Filed Jul 14, 2025
Insider Transaction Report
Form 4
Palasis Maria
DirectorPresident & CEO
Transactions
- Sale
Common Stock
2025-07-10$8.91/sh−1,565$13,944→ 1,098,435 total
Footnotes (1)
- [F1]Shares were sold to cover taxes upon the vesting of restricted stock units ("RSUs") pursuant to a mandatory Rule 10b5-1 trading instruction in the award agreement adopted by the Reporting Person on January 1, 2025 in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended.